Science Exchange Collaborates with Renovo Neural to Offer Novel Neurological Research Services

PALO ALTO, Calif.–(BUSINESS WIRE)–Science Exchange, the leading marketplace for outsourced R&D, announced
today a collaboration with Renovo
, a Contract Research Organization (CRO) specializing in
degenerative neurological conditions.

Renovo has a history in model development for multiple sclerosis (MS)
and recently expanded its efforts to offer other non-clinical research
services such as immunohistochemistry and 3-D electron microscopy for a
wide range of neurological disorders, including Parkinson’s Disease,
Alzheimer’s Disease, and Charcot-Marie-Tooth Syndrome. Renovo is best
known for having developed an augmented cuprizone model of MS. This
model – developed by the pioneering work of Bruce Trapp and Wendy
Macklin – has been documented to provide superior reliability in
evaluating the remyelination potential of novel therapeutic candidate
compounds. Renovo has an experienced team and proven capabilities to
support research and development in neurology.

“While Renovo is already well-known in the field, collaborating with
Science Exchange will help expand our reach to researchers who can
benefit from the technical expertise our team can provide,” stated Vivek
Shenoy, CEO of Renovo. “We will be in a better position to support R&D
teams actively involved in the discovery of new therapies to treat or
even reverse the debilitating effects of MS and other neurodegenerative

“We are very excited to collaborate with Renovo Neural to make its novel
neurological research services readily available to scientists
worldwide,” said Elizabeth Iorns, Ph.D., co-founder and CEO of Science
Exchange. “Science Exchange is committed to adding the most innovative
and qualified service providers to our platform, so scientists have
secure, rapid access to the services they need to aid their discoveries.
Renovo Neural has impressed us with their progress in the field of
neurodegenerative diseases.”

About Science Exchange

Science Exchange is the world’s leading marketplace for outsourced R&D,
providing large R&D organizations with the fastest path from discovery
through development and commercialization. Science Exchange includes an
efficient source-to-secure platform for ordering 6,000+ services from a
network of more than 2,500 qualified outsourced research providers, all
with pre-established contracts in place that protect client intellectual
property and confidentiality. The platform increases access to
innovation and improves productivity, freeing scientists from
administrative tasks and delays associated with sourcing, establishing
and managing service provider contracts. Additionally, the Science
Exchange enterprise program enables large R&D organizations to
consolidate research outsourcing spend into a single strategic
relationship, driving efficiency, improving transparency and oversight,
and delivering cost savings. Since being founded in 2011, Science
Exchange has raised more than $58 million from Norwest Venture Partners,
Maverick Capital Ventures, Union Square Ventures, Collaborative Fund,
Index Ventures, OATV, the YC Continuity Fund, and others. For more
information, visit
Follow the company on Twitter @ScienceExchange,
and LinkedIn.

About Renovo Neural

Neural, Inc
. is a private CRO operating in Cleveland, Ohio, for the
past 10 years. The company was co-founded by Dr. Wendy Macklin and Dr.
Bruce Trapp, Chief Scientific Officer of Renovo and the current chair of
the Neuroscience Department at the Lerner Research Institute at the
Cleveland Clinic. Drs. Macklin and Trapp are both recognized as
world-renowned experts in Multiple Sclerosis research. The company
offers pre-clinical / non-clinical translational research services with
a focus on the evaluation of neuro-therapeutics.


Science Exchange
Gursatya “Guru” Singh
of Scientific Content
Neural, Inc.
Chris Ryan, +1 216-445-4202
Director, Business Development